Grant RadarWorldwide funding

Browse grants Log in Get started

Health Open for ApplicationsRFA-DA-25-024

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

National Institutes of Health opportunity RFA-DA-25-024

Eligible Applicants

Organization Types

UniversitiesNGOsSMEsGovernment Agencies

Eligible Countries / Regions

United States

Keywords

National Institutes of HealthRFA-DA-25-024Grants.gov

Related Grants

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Amount not stated

05 Nov 2028(730d)

Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)

Amount not stated

02 Nov 2028(727d)

Establishing Pediatric CNS Pharmacodynamic Measures as Tools to Enable Psychiatric Indications in Adolescents

Amount not stated

Research Project Cooperative Agreements in Aging and/or Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) Research

Amount not stated

Funding Amount

Amount not stated

USD

The funder has not published an amount yet — check the call documents.

Application Deadline

6 March 2027

120 days remaining

Opens: 2 Aug 2024

Programme Details

Programme Code

RFA-DA-25-024